Meeting NewsVideo

VIDEO: Heart failure most deadly complication of type 2 diabetes

PHILADELPHIA — In this video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, professor of medicine at the University of Missouri-Kansas City and a conference co-chair, discusses the intersection of diabetes, prediabetes and heart failure.

According to Kosiborod, the survival rate in older patients with heart failure may be as poor as less than 25% in 5 years, so effective treatments and treatment strategies are need to both prevent and effectively manage heart failure, particularly in those with preexisting type 2 diabetes.

SGLT2 inhibitors may be effective and have been shown to potentially prevent heart failure in patients with diabetes and improve a number of other important cardiovascular outcomes.

“They are being actively studied in patients with established heart failure in multiple clinical trials, including several large outcome trials,” Kosiborod said.

PHILADELPHIA — In this video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, professor of medicine at the University of Missouri-Kansas City and a conference co-chair, discusses the intersection of diabetes, prediabetes and heart failure.

According to Kosiborod, the survival rate in older patients with heart failure may be as poor as less than 25% in 5 years, so effective treatments and treatment strategies are need to both prevent and effectively manage heart failure, particularly in those with preexisting type 2 diabetes.

SGLT2 inhibitors may be effective and have been shown to potentially prevent heart failure in patients with diabetes and improve a number of other important cardiovascular outcomes.

“They are being actively studied in patients with established heart failure in multiple clinical trials, including several large outcome trials,” Kosiborod said.

    See more from Heart in Diabetes